16315-07-4

Basic information

• Product Name: 1-methoxy-2,3-dinitrobenzene
• Synonyms: .alpha.-Dinitroanisole; 2,3-Dinitrophenyl methyl ether; benzene, 1-methoxy-2,3-dinitro-; Dinitroanisole
• CAS NO: 16315-07-4
• Molecular Formula: C₇H₆N₂O₅
• Molecular Weight: 198.1329
• Mol File: 16315-07-4.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 376.2°C at 760 mmHg
• Flash Point: 197°C
• Density: 1.444g/cm³
• Vapor Pressure: 1.59E-05mmHg at 25°C
• Refractive Index: 1.586
• CAS DataBase Reference: 1-methoxy-2,3-dinitrobenzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-methoxy-2,3-dinitrobenzene(16315-07-4)
• EPA Substance Registry System: 1-methoxy-2,3-dinitrobenzene(16315-07-4)

Safety Data

• Hazardous Substances Data: 16315-07-4(Hazardous Substances Data)

Usage

Appearance

Pale yellow solid This describes the physical appearance of the compound, which is a pale yellow solid substance.

Usage as a precursor

Synthesis of pharmaceuticals and dyes 1-methoxy-2,3-dinitrobenzene is commonly used as a starting material in the production of various pharmaceuticals and dyes due to its reactive chemical properties.

Usage as a stabilizer

Production of organic peroxides The compound is also used to stabilize organic peroxides during their production, which helps prevent unwanted reactions and ensures a safer process.

Skin irritant

Strong irritant This property indicates that 1-methoxy-2,3-dinitrobenzene can cause significant skin irritation upon contact, necessitating proper handling and protective measures.

Eye irritant

Strong irritant Similar to its skin irritation properties, the compound can also cause severe eye irritation, making it essential to avoid contact with the eyes.

Respiratory irritant

Strong irritant 1-methoxy-2,3-dinitrobenzene can cause respiratory issues when inhaled, so proper ventilation and personal protective equipment should be used to minimize exposure.

Upstream product

• 109-95-5 ethyl nitrite 
• 5473-00-7 4-methoxy-2,3-dinitro-aniline 
• 555-03-3 3-nitroanisole 
• 66-56-8 2,3-dinitrophenol 
• 77-78-1 dimethyl sulfate 
• 7697-37-2 nitric acid 
• 74-88-4 methyl iodide 
• 61153-03-5 trimethylsilyl diazomethane 
• 51-66-1 4-methoxyacetanilide 
• 62153-30-4 acetic acid-(4-methoxy-2,3-dinitro-anilide) 
• 119-81-3 4-methoxy-2-nitroacetanilide 

Downstream Products

• 116668-84-9 3-nitroveratrole 
• 66-56-8 2,3-dinitrophenol 
• 37466-89-0 3-methoxybenzene-1,2-diamine 
• 16554-45-3 2-methoxy-6-nitroaniline 
• 116779-65-8 2,3,4-trinitro-anisole 
• 7575-27-1 2-methoxy-6-nitro-N-phenylaniline 
• 603-84-9 2-chloro-3-nitrophenol 
• 38469-85-1 2-methoxy-6-nitrobenzonitrile 
• 18523-14-3 1,3-dimethoxy-2,4-dinitro-benzene 
• 3970-39-6 2-chloro-3-methoxynitrobenzene 
• 860767-58-4 1,3-diethoxy-2,4-dinitro-benzene 
• 116496-81-2 acetic acid-(2-methoxy-6-nitro-anilide) 
• 2876-17-7 1-methoxyphenazine 
• 410092-91-0 N-methyl-2-methoxy-6-nitroaniline 

Relevant articles and documents

BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF GLYTL MEDIATED DISORDERS

The present invention relates to benzoxazinone derivatives, processes for their preparation, pharmaceutical compositions and medicaments containing them and to their use in treating disorders mediated by GlyT1, including neurological and neuropsychiatric disorders, in particular psychoses, dementia or attention deficit disorder.

Benzimidazoles and analogs thereof as antivirals

Provided are compounds of the formula: wherein RN1 is a substituent of formula G1-NX1X2, wherein G1 is an optionally further substituted alkylene, which optionally forms, together with RN2,